Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: Trends and correlations

The global increase in incidence of cutaneous malignant melanoma (CMM) occurring in the past decades has been partly attributed to increased diagnostic scrutiny of early lesions, with a potential phenomenon of overdiagnosis. The reported positive linear relation between skin biopsy rate and incidence of early CMM is compatible with this hypothesis.

[1]  D. Whiteman,et al.  The effect of screening on melanoma incidence and biopsy rates , 2022, The British journal of dermatology.

[2]  J. Grant-Kels,et al.  Evidence concerning the accusation that melanoma is overdiagnosed , 2021, Journal of the American Academy of Dermatology.

[3]  C. Garbe,et al.  Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943-2036. , 2021, European journal of cancer.

[4]  H. Welch,et al.  The Rapid Rise in Cutaneous Melanoma Diagnoses. , 2021, The New England journal of medicine.

[5]  S. Rosso,et al.  Mid‐term trends and recent birth‐cohort‐dependent changes in incidence rates of cutaneous malignant melanoma in Italy , 2020, International journal of cancer.

[6]  J. Emery,et al.  Dermoscopy for melanoma detection and triage in primary care: a systematic review , 2019, BMJ Open.

[7]  S. Feldman,et al.  Assessment of Provider Utilization Through Skin Biopsy Rates. , 2019, Dermatologic Surgery.

[8]  S. Swetter,et al.  Evaluation of the Number-Needed-to-Biopsy Metric for the Diagnosis of Cutaneous Melanoma: A Systematic Review and Meta-analysis. , 2019, JAMA dermatology.

[9]  A. Gavin,et al.  Trends in incidence of thick, thin and in situ melanoma in Europe. , 2018, European journal of cancer.

[10]  P. Rubegni,et al.  Thick melanoma in Tuscany. , 2019, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[11]  C. Watts.  The challenge of skin surveillance: observe or biopsy? , 2017, The British journal of dermatology.

[12]  M. Weinstock,et al.  Skin biopsy utilization and melanoma incidence among Medicare beneficiaries , 2017, The British journal of dermatology.

[13]  Alexander Katalinic,et al.  Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: A systematic review , 2017, Journal of the American Academy of Dermatology.

[14]  P. Ascierto,et al.  Sun exposure and melanoma prognostic factors , 2016, Oncology letters.

[15]  Stephen W Dusza,et al.  Melanoma Thickness and Survival Trends in the United States, 1989 to 2009. , 2016, Journal of the National Cancer Institute.

[16]  W. Mooi,et al.  Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations? , 2015, European journal of cancer.

[17]  G. Salerni,et al.  A series of small-diameter melanomas on the legs: dermoscopic clues for early recognition , 2015, Dermatology practical & conceptual.

[18]  S. Rosso,et al.  Sun Exposure and Melanoma Survival: A GEM Study , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[19]  I. Zalaudek,et al.  Melanoma detection in Italian pigmented lesion clinics. , 2014, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[20]  J. Lortet-Tieulent,et al.  International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk? , 2013, International journal of cancer.

[21]  Ken Kobayashi,et al.  Accuracy in melanoma detection: a 10-year multicenter survey. , 2012, Journal of the American Academy of Dermatology.

[22]  H. Karim-Kos,et al.  Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  W. Weyers,et al.  The ‘epidemic’ of melanoma between under‐ and overdiagnosis , 2012, Journal of cutaneous pathology.

[24]  Esther de Vries,et al.  Incidence and trends of cutaneous malignancies in the Netherlands, 1989-2005. , 2010, The Journal of investigative dermatology.

[25]  Timo Hakulinen,et al.  Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964–2003 followed up to the end of 2006 , 2010, Acta oncologica.

[26]  A. Gavin,et al.  Cutaneous melanoma mortality starting to change: a study of trends in Northern Ireland. , 2009, European journal of cancer.

[27]  S M Goldsmith,et al.  A series of melanomas smaller than 4 mm and implications for the ABCDE rule , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[28]  J. Aitken,et al.  Trends for in situ and Invasive Melanoma in Queensland, Australia, 1982–2002 , 2006, Cancer Causes & Control.

[29]  Lisa M. Schwartz,et al.  Skin biopsy rates and incidence of melanoma: population based ecological study , 2005, BMJ : British Medical Journal.

[30]  S. Rosso,et al.  Population-based incidence and mortality cancer trends (1986–1997) from the network of Italian cancer registries , 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[31]  F. Bray,et al.  Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: Rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia , 2003, International journal of cancer.

[32]  P. Carli,et al.  Unexpected reduction of mortality rates from melanoma in males living in central Italy. , 2003, European journal of cancer.

[33]  Vincenzo De Giorgi,et al.  The problem of false‐positive diagnosis in melanoma screening: the impact of dermoscopy , 2003, Melanoma research.

[34]  M. Nicolson,et al.  Incidence of and survival from malignant melanoma in Scotland: an epidemiological study , 2002, The Lancet.

[35]  U. Ringborg,et al.  Trends in Incidence of Cutaneous Malignant Melanoma in a Swedish Population 1976-1994 , 2002, Acta oncologica.

[36]  C. Balch,et al.  AJCC Cancer Staging Manual. 6th ed , 2002 .

[37]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[38]  K. Jöckel,et al.  Skin melanoma in Saarland: incidence, survival and mortality 1970–1996 , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[39]  B. Armstrong,et al.  Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983–1996 , 2001, International journal of cancer.

[40]  J. Pitha,et al.  Small‐diameter invasive melanomas: clinical and pathologic characteristics , 1996, Journal of cutaneous pathology.